|1||Active, not recruiting||
Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma
|2||Active, not recruiting||
Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
|3||Not yet recruiting||
A Phase II Study of Pembrolizumab in Refractory Advanced Esophageal Cancer
Study of Vitamin D in Untreated Metastatic Colorectal Cancer
† Study has passed its completion date and status has not been verified in more than two years.